Holocene Advisors’s Keros Therapeutics KROS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-1,199,990
Closed -$19M 821
2024
Q4
$19M Buy
1,199,990
+356,880
+42% +$5.65M 0.06% 252
2024
Q3
$49M Buy
843,110
+154,784
+22% +$8.99M 0.2% 147
2024
Q2
$31.5M Buy
688,326
+50,343
+8% +$2.3M 0.13% 175
2024
Q1
$42.2M Buy
+637,983
New +$42.2M 0.16% 164